118 related articles for article (PubMed ID: 2638374)
1. Quantitative grading of Leishmania donovani amastigotes related to age of kala-azar patients.
Saran R; Sharma MC; Sen AB
J Commun Dis; 1989 Dec; 21(4):262-4. PubMed ID: 2638374
[TBL] [Abstract][Full Text] [Related]
2. Observations on human bone-marrow for Leishmania donovani.
Rajendran P; Chatterjee SN; Gupta JB
Indian J Pathol Microbiol; 1989 Oct; 32(4):282-5. PubMed ID: 2632416
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological study of clinically undiagnosed cases of kala-azar with special reference to grading of parasites.
Mukherjee C; Mitra PK; Dasgupta A; Ghosh RN
J Indian Med Assoc; 1995 Mar; 93(3):87-9. PubMed ID: 8522820
[TBL] [Abstract][Full Text] [Related]
4. The effect of age and sex on incidence of kala-azar.
Sharma MC; Gupta AK; Saran R; Sinha SP
J Commun Dis; 1990 Dec; 22(4):277-8. PubMed ID: 2098434
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological study of kala-azar by direct agglutination test in two rural communities of eastern Nepal.
Koirala S; Karki P; Das ML; Parija SC; Karki BM
Trop Med Int Health; 2004 Apr; 9(4):533-7. PubMed ID: 15078273
[TBL] [Abstract][Full Text] [Related]
6. Kala-azar in Uttar Pradesh--a study of 66 patients.
Mittal V; Singh VK; Ichhpujani RL
J Commun Dis; 2002 Mar; 34(1):43-9. PubMed ID: 12718341
[TBL] [Abstract][Full Text] [Related]
7. Quantitative grading of Leishmania donovani amastigotes in bone marrow aspirates smears.
Hati AK; De N
Indian J Med Res; 1986 Sep; 84():275-8. PubMed ID: 3817928
[No Abstract] [Full Text] [Related]
8. Leishmanin skin test in clinical and subclinical kala-azar cases.
Saran R; Gupta AK; Sharma MC
J Commun Dis; 1991 Jun; 23(2):135-7. PubMed ID: 1940219
[TBL] [Abstract][Full Text] [Related]
9. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis.
Subba Raju BV; Singh R; Sreenivas G; Singh S; Salotra P
Parasitology; 2008 Jan; 135(Pt 1):23-32. PubMed ID: 17761024
[TBL] [Abstract][Full Text] [Related]
10. Clinicoepidemiological profile of kala azar patients in Delhi.
Mittal V; Bhatia R; Sehgal S
J Commun Dis; 1989 Dec; 21(4):255-61. PubMed ID: 2638373
[TBL] [Abstract][Full Text] [Related]
11. Visceral leishmaniasis in Nepal during 1980-2006.
Joshi DD; Sharma M; Bhandari S
J Commun Dis; 2006 Mar; 38(2):139-48. PubMed ID: 17370676
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous parasitism by Leishmania (Leishmania) chagasi during South American visceral leishmaniasis].
Vasconcelos Ide A; Sousa Ade Q; Vasconcelos AW; Diógenes MJ; Momen H; Grimaldi Júnior G; Menezes DB; Sleigh AC
Bull Soc Pathol Exot; 1993; 86(2):101-5. PubMed ID: 8353466
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of symptomatic kala-azar by polymerase chain reaction using patient's blood.
Pal S; Aggarwal G; Haldar A; Majumdar A; Majumdar HK; Duttagupta S
Med Sci Monit; 2004 Jan; 10(1):MT1-5. PubMed ID: 14704640
[TBL] [Abstract][Full Text] [Related]
14. LD body-negative bone marrow cases of kala-azar in Dharan, Nepal.
Karki P; Parija SC; Koirala S
J Commun Dis; 1999 Dec; 31(4):261-2. PubMed ID: 10937305
[No Abstract] [Full Text] [Related]
15. Comparative susceptibility of African green monkeys (Cercopithecus aethiops) to experimental infection with Leishmania leishmania donovani and Leishmania leishmania infantum.
Binhazim AA; Shin SS; Chapman WL; Olobo J
Lab Anim Sci; 1993 Feb; 43(1):37-47. PubMed ID: 8459677
[TBL] [Abstract][Full Text] [Related]
16. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
Schenkel K; Rijal S; Koirala S; Koirala S; Vanlerberghe V; Van der Stuyft P; Gramiccia M; Boelaert M
Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
[TBL] [Abstract][Full Text] [Related]
18. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
Manna M; Majumder HK; Sundar S; Bhaduri AN
Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
[TBL] [Abstract][Full Text] [Related]
19. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.
Thakur CP; Sinha GP; Pandey AK; Barat D; Singh RK
Bull World Health Organ; 1994; 72(6):931-6. PubMed ID: 7867139
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiological study on kala-azar in Baringo District, Kenya.
Jahn A; Lelmett JM; Diesfeld HJ
J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
